Alix-Pharma.com
Title
AliX : protein crystallography and structure-based drug design
Description
Excerpted from the website:
- Created end of 2002 as a spin-off from the Department of Structural Biology and Genomics of IGBMC (Institute of Genetics and Molecular and Cellular Biology) in Strasbourg-Illkirch, AliX is an early-stage drug discovery company dedicated to structure-based drug design using X-ray crystallography, with a main interest in nuclear hormone receptors.
Additional Information
External Links
Categories:
- Alix
- Alix-pharma
- Biologie Structurale
- Structural Biology
- Cellular
- IGBMC
- Genomics
- X-ray
- Crystallization
- Drug Discovery
- Purification
- Nuclear Hormone Receptors
- Screening
- Fragment-base
- Fragment Analysis
- Docking
- Active Site
- Target
- Binding Mode
- PPAR
- LXR
- FXR
- RAR
- ROR
- RXR
- VDR
- ER
- ERR
- NURR1
- NOR
- TR
- Ligand Screening
- Recepteur Nucléaire
- Nuclear Receptor
- Crystallography
- Mass Spectrométry
- Therapeutic Pharmaceutical Interest
- Crystallography Services